Icatibant er en ny behandlingsmulighed ved livstruende angiotensinkonverterende enzym-inhibitor-udløst angioødem

Ugeskrift for Laeger

Volumn 173, Issue 41, 2011, Pages 2574-2575

  Fast, Søren ^a   Henningsen, Emil ^a   Bygum, Anette ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; ENALAPRIL; ICATIBANT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; ENALAPRIL; FEMALE; HUMANS;

EID: 84857734341     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Sanchez-Borges M, Gonzalez-Aveledo LA. Angiotensin-converting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2010;2:195-8.
2. Nussberger J, Cugno M, Amstutz C et al. Plasma bradykinin in angio-oedema. Lancet 1998;351:1693-7.
3. Bork K, Frank J, Grundt B et al. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (icatibant). J Allergy Clin Immunol 2007;119:1497-503.
4. Vleeming W, van Amsterdam JG, Stricker BH et al. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998;18:171-88.
5. Bas M, Greve J, Stelter K et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 2010;56:278-82.